| Copper | Approved Investigational | CLGN | 1047 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLGN mRNA | 4q31.1 | |
| Copper | Approved Investigational | CLIC3 | 9022 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLIC3 mRNA | 9q34.3 | |
| Copper | Approved Investigational | CLINT1 | 9685 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLINT1 mRNA | 5q33.3 | |
| Copper | Approved Investigational | CLIP1 | 6249 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLIP1 mRNA | 12q24.31 | |
| Copper | Approved Investigational | CLIP4 | 79745 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLIP4 mRNA | 2p23.2 | |
| Copper | Approved Investigational | CLN6 | 54982 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CLN6 mRNA | 15q23 | |
| Copper | Approved Investigational | CLN8 | 2055 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLN8 mRNA | 8p23.3 | |
| Copper | Approved Investigational | CLP1 | 10978 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CLP1 mRNA | 11q12.1 | |
| Copper | Approved Investigational | CLTA | 1211 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CLTA mRNA | 9p13.3 | |
| Copper | Approved Investigational | CLU | 1191 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLU mRNA | 8p21.1 | |
| Copper | Approved Investigational | CLUH | 23277 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CLUH mRNA | 17p13.3 | |
| Copper | Approved Investigational | CMBL | 134147 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CMBL mRNA | 5p15.2 | |
| Copper | Approved Investigational | CMTM7 | 112616 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CMTM7 mRNA | 3p22.3 | |
| Copper | Approved Investigational | CNKSR2 | 22866 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CNKSR2 mRNA | Xp22.12 | |
| Copper | Approved Investigational | CNTNAP1 | 8506 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CNTNAP1 mRNA | 17q21.2 | |
| Copper | Approved Investigational | COCH | 1690 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of COCH mRNA | 14q12 | |
| Copper | Approved Investigational | COL11A1 | 1301 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of COL11A1 mRNA | 1p21.1 | |
| Copper | Approved Investigational | COL12A1 | 1303 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of COL12A1 mRNA | 6q13-q14.1 | |
| Copper | Approved Investigational | COL1A2 | 1278 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of COL1A2 mRNA | 7q21.3 | |
| Copper | Approved Investigational | COL1A2 | 1278 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of COL1A2 mRNA | 7q21.3 | |
| Copper | Approved Investigational | COL3A1 | 1281 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of COL3A1 mRNA | 2q32.2 | |
| Copper | Approved Investigational | COL4A1 | 1282 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of COL4A1 mRNA | 13q34 | |
| Copper | Approved Investigational | COL5A1 | 1289 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of COL5A1 mRNA | 9q34.3 | |
| Copper | Approved Investigational | COL5A2 | 1290 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of COL5A2 mRNA | 2q32.2 | |
| Copper | Approved Investigational | COMMD9 | 29099 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of COMMD9 mRNA | 11p13 | |